Association between serum insulin levels and heart failure-related parameters in patients with type 2 diabetes and heart failure treated with canagliflozin: a post-hoc analysis of the randomized CANDLE trial

被引：0
|
作者：
Atsushi Tanaka
Takumi Imai
Michio Shimabukuro
Isao Taguchi
Akira Sezai
Shigeru Toyoda
Hirotaka Watada
Junya Ako
Koichi Node
机构：
[1] Saga University,Department of Cardiovascular Medicine
[2] Osaka Metropolitan University,Department of Medical Statistics, Graduate School of Medicine
[3] Fukushima Medical University,Department of Diabetes, Endocrinology, and Metabolism
[4] Dokkyo Medical University Saitama Medical Center,Department of Cardiology
[5] Nihon University School of Medicine,Department of Cardiovascular Surgery
[6] Dokkyo Medical University School of Medicine,Department of Cardiovascular Medicine
[7] Juntendo University Graduate School of Medicine,Department of Metabolism & Endocrinology
[8] Kitasato University School of Medicine,Department of Cardiovascular Medicine
来源：
Cardiovascular Diabetology | / 21卷
关键词：
Type 2 diabetes; Chronic heart failure; Canagliflozin; Glimepiride; Insulin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 31 条
  • [21] Changes in serum levels of liver-related parameters, uric acid, and hemoglobin in patients with type 2 diabetes mellitus under treatment with tofogliflozin-a post-hoc analysis of the UTOPIA study
    Katakami, Naoto
    Mita, Tomoya
    Sato, Yasunori
    Watada, Hirotaka
    Shimomura, Iichiro
    DIABETOLOGY INTERNATIONAL, 2024, 15 (03) : 379 - 388
  • [22] Association of triglyceride-glucose index trajectories with the risk of worsening heart failure in elderly patients with chronic heart failure and type 2 diabetes: a competing risk analysis
    Lai, Yingying
    Lin, Cailong
    Liu, Xindong
    Liu, Yuting
    Cai, Hua
    Zhao, Nannan
    Gao, Yushuo
    Yi, Ziyi
    Huang, Jianyu
    Li, Min
    Xu, Lin
    CARDIOVASCULAR DIABETOLOGY, 2025, 24 (01)
  • [23] Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial
    Mantovani, Alessandro
    Targher, Giovanni
    Temporelli, Pier Luigi
    Lucci, Donata
    Gonzini, Lucio
    Nicolosi, Gian Luigi
    Marchioli, Roberto
    Tognoni, Gianni
    Latini, Roberto
    Cosmi, Franco
    Tavazzi, Luigi
    Maggioni, Aldo Pietro
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2018, 83 : 205 - 215
  • [24] Efficacy and safety of adding liraglutide to existing insulin regimens in Japanese patients with type2 diabetes mellitus: A post-hoc analysis of a phase3 randomized clinical trial
    Kaneko, Shizuka
    Nishijima, Keiji
    Bosch-Traberg, Heidrun
    Kaku, Kohei
    Seino, Yutaka
    JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (04) : 840 - 849
  • [25] Relationship between B-type natriuretic peptide plasma levels and echocardiography parameters in decompensated chronic heart failure patients treated with levosimendan
    MB Ferri
    RH Passos
    M Knobel
    M Nigri
    EJA Figueiredo
    RD Morsch
    P Silveira
    JMA Souza
    A Perez
    Critical Care, 10 (Suppl 1):
  • [26] Relationship between B-type natriuretic peptide plasma levels and echocardiography parameters in compensated chronic heart failure patients treated with levosimendan
    EJ de Almeida Figueiredo
    A Perez
    E Knobel
    JMA Souza
    MB Ferri
    M Knobel
    M Nigri
    P Silveira
    RD Morsch
    RH Passos
    Critical Care, 11 (Suppl 3):
  • [27] Real-world comparison of hospitalization costs for heart failure in type 2 diabetes mellitus patients with established cardiovascular disease treated with canagliflozin versus other antihyperglycemic agents
    Chen, Yen-Wen
    Voelker, Jennifer
    Tunceli, Ozgur
    Pericone, Christopher D.
    Bookhart, Brahim
    Durkin, Michael
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (04) : 401 - 406
  • [28] Effects of 18-months metformin versus placebo in combination with three insulin regimens on RNA and DNA oxidation in individuals with type 2 diabetes: A post-hoc analysis of a randomized clinical trial
    Larsen, Emil List
    Kjaer, Laura K.
    Lundby-Christensen, Louise
    Boesgaard, Trine W.
    Breum, Leif
    Gluud, Christian
    Hedetoft, Christoffer
    Krarup, Thure
    Lund, Soren S.
    Mathiesen, Elisabeth R.
    Perrild, Hans
    Sneppen, Simone B.
    Tarnow, Lise
    Thorsteinsson, Birger
    Vestergaard, Henrik
    Poulsen, Henrik E.
    Madsbad, Sten
    Almdal, Thomas P.
    FREE RADICAL BIOLOGY AND MEDICINE, 2022, 178 : 18 - 25
  • [29] Combination of Qi Benefiting and Blood Circulation Promoting Herbs with Dapagliflozin in the Treatment of Type 2 Diabetes Mellitus Combined with Heart Failure: A Systematic Evaluation and Meta-Analysis Based on a Randomized Controlled Trial
    Liu, Changxing
    Guo, Xinyi
    Wang, He
    Zhou, Yabin
    COMPLEMENTARY MEDICINE RESEARCH, 2024, 31 (06) : 551 - 566
  • [30] Association between sodium glucose co-transporter 2 inhibitors and a reduced risk of heart failure in patients with type 2 diabetes mellitus: a real-world nationwide population-based cohort study
    Kim, Young-Gun
    Han, Seung Jin
    Kim, Dae Jung
    Lee, Kwan-Woo
    Kim, Hae Jin
    CARDIOVASCULAR DIABETOLOGY, 2018, 17
1234